Lumexa Imaging Holdings, Inc. (LMRI) Stock Analysis

Q: What is the LMRI stock price target?

Take-profit $16.41 (+72.9% upside). Target $16.41 (+72.9%), stop $8.83 (−7.5%), A.R:R 5.8:1.

Q: What are the risks of investing in LMRI?

Market cap $0.90B below $1B minimum; Market cap $0.90B below $1B minimum.

Range Bound setup

HoldModerate ConfidenceUpdated 2026-04-30

Healthcare · Medical Devices

Hold if already holding. Not a fresh buy at $9.49, but acceptable to hold if already in. Reason: Market cap $0.90B below $1B minimum.

$9.49+72.9% A.UpsideScore 5.4/10#19 of 40 Medical Devices

Stop $8.83Target $16.41(analyst − 13%)A.R:R 5.8:1

Analyst target$18.86+98.7%7 analysts

$16.41our TP

$9.49price

$18.86mean

$23

Hold if already holding. Not a fresh buy at $9.49, but acceptable to hold if already in. Reason: Market cap $0.90B below $1B minimum. Chart setup: RSI 52 mid-range, Bollinger mid-band. Market cap $0.90B below $1B minimum. Not in investable universe. Score 5.4/10, moderate confidence.

Passes 6/7 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Suitability: aggressive.

Thesis

Rewards

No bull case signals

Risks

Market cap $0.90B below $1B minimum

Key Metrics

P/E (TTM)—

P/E (Fwd)9.6

Mkt Cap$901M

EV/EBITDA19.6

Profit Mgn-4.6%

ROE-12.6%

Rev Growth7.9%

Beta—

DividendNone

Rating analysts14

Quality Signals

Piotroski F5/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

4 floor-breakers

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value7.615%1.14

Quality2.215%0.33

Growth7.215%1.08

Momentum5.810%0.58

Sentiment8.010%0.80

Insider Activity5.110%0.51

Peer Rank3.910%0.39

Technical Setup3.35%0.17

Risk Profile4.75%0.24

Catalyst2.95%0.14

Overall (Σ contributions)5.37

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Unprofitable operations — net margin -4.6%. Quality floor flags this regardless of sector context.static

Roe

0.0

Gross Margin

0.0

Net Margin

0.0

Operating Margin

0.7

Roa

1.3

Current Ratio

4.8

Moat

5.0

Piotroski F

5.6

No competitive moatQuality concerns

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History

0.0

Surprise Avg

0.0

Earnings Timing

5.0

Erm

6.5

Earnings in 12 days

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position

0.0

Bollinger

4.4

Support Resistance

5.4

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank

3.1

Growth Rank

3.8

Value Rank

8.8

GatesEARNINGS PROXIMITY 12d<=14d (soft)Momentum 5.8>=5.5A.R:R 5.8 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive

RSI

52 · Neutral

↑ 20D MA↓ 50D MA↓ 200D MASupport $8.75Resistance $10.35

Price Targets

$16

A.Upside+72.9%

A.R:R5.8:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeSteady

Risk Alerts

! Market cap $0.90B below $1B minimum

Earnings

0/4 beats

Next Earnings2026-05-12 (12d)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is LMRI stock a buy right now?

Hold if already holding. Not a fresh buy at $9.49, but acceptable to hold if already in. Reason: Market cap $0.90B below $1B minimum. Chart setup: RSI 52 mid-range, Bollinger mid-band. Market cap $0.90B below $1B minimum. Not in investable universe. Target $16.41 (+72.9%), stop $8.83 (−7.5%), A.R:R 5.8:1. Score 5.4/10, moderate confidence.

What is the LMRI stock price target?

Take-profit target: $16.41 (+72.9% upside). Target $16.41 (+72.9%), stop $8.83 (−7.5%), A.R:R 5.8:1. Stop-loss: $8.83.

What are the risks of investing in LMRI?

Market cap $0.90B below $1B minimum.

Is LMRI overvalued or undervalued?

Lumexa Imaging Holdings, Inc. trades at a P/E of N/A (forward 9.6). TrendMatrix value score: 7.6/10. Verdict: Hold.

What do analysts say about LMRI?

14 analysts cover LMRI with a consensus score of 4.4/5. Average price target: $19.

What does Lumexa Imaging Holdings, Inc. do?Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides...

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.